Emergent BioSolutions has entered a strategic financial investment agreement with Swiss Rockets to support infrastructure ...

Emergent BioSolutions is investing in Swiss biotech Rocketvax, inking a deal designed to fuel the preclinical company’s R&D.

Emergent BioSolutions Inc. (NYSE: EBS), a leading public health company that delivers protective and life-saving solutions to communities across the world, and Rocketvax Ltd, one of Switzerland’s next ...

Emergent BioSolutions (EBS) and Rocketvax announced entry into an agreement for Emergent’s strategic financial investment into Swiss Rockets, ...

I bet that stance softens come June. – 11:31 PM The Warriors gained two games on the Rockets the last two nights. Traffic remains below them, but fifth seed becoming more plausible. They’re ...

The Houston Rockets have won their last two games ... of the best and most versatile defense in the league. "With his Swiss Army knife-like game, offense from VanVleet, Jalen Green and Alperen ...

Heading into the All-Star break, the Rockets could use a reset. Yes, this team has been banged up recently, and the losses of both Jabari Smith Jr. and Fred VanVleet (along with the game ...

As part of the investment, Emergent would lead U.S. manufacturing and commercialization efforts for four of Rocketvax’s ...